Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brief Counseling vs Orlistat for Weight Management
NCT00212199Phase 4Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of orlistat in obesity (3 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoints: Changes in body weight at 24 months and Changes in body mass index at 24 months. Started Jan 2002; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00212199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212199.